Assessment of Preclinical Target Organ Damage in Hypertension
Assessment of Preclinical Target Organ Damage in Hypertension
In the natural history of hypertension, the compensatory increase in left ventricular mass ceases to be beneficial. Left ventricular hypertrophy (LVH) becomes a preclinical disease and an independent risk factor for congestive heart failure, ischemic heart disease, arrhythmia, sudden death, and stroke. In addition to elevated BP, several mechanisms are involved, including body size, age, gender, race, fibrogenic cytokines, and neurohumoral factors, notably angiotensin II, which favor interstitial collagen deposition and perivascular fibrosis. These tissue changes are responsible for the insidious contractile dysfunction that is associated with LVH, consequent to decreased coronary reserve and altered diastolic ventricular filling and relaxation. The cardinal investigations are echocardiography and electrocardiography. All antihypertensive drugs regress LVH, notably those that act on the renin-angiotensin-aldosterone system, which also could target the detrimental tissue changes. Regression enhances systolic midwall performance, normalizes autonomic function, and restores coronary reserve.
Related Conference of Assessment of Preclinical Target Organ Damage in Hypertension
April 23-24, 2025
14th International Conference on Cardiology and Cardiovascular Medicine Research
Paris, France
June 19-20, 2025
12th World Congress on Hypertension, Cardiology, Primary Health and Patient Care
Paris, France
July 21-22, 2025
33rd International Congress on Cardiology and Medical Interventions
Toronto, Canada
July 24-25, 2025
8th International Conference on Cardiovascular Diseases and Therapeutics
Paris, France
August 21-22, 2025
34th International Conference on Clinical and Experimental Cardiology Research
Vancouver, Canada
September 25-26, 2025
13th International Conference on Hypertension and Healthcare
Zurich, Switzerland
October 22-23, 2025
12th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care
Paris, France
November 03-04, 2025
12th International Conference on Hypertension and Cardiovascular Diseases
Rome, Italy
November 18-19, 2025
26th International Conference on New Horizons in Cardiology and Cardiologists Education
Paris, France
Assessment of Preclinical Target Organ Damage in Hypertension Conference Speakers
Recommended Sessions
- Assessment of Preclinical Target Organ Damage in Hypertension
- Cardiovascular Risk Profile and Antihypertensive Treatment
- Clinical trials in Hypertension patients & Clinical case Reports
- Complications of uncontrolled hypertension
- Diet and Exercise for Hypertension and Cardiovascular Prevention
- High Blood Pressure, Alcohol and Cardiovascular Risk
- Hypertension , Coronary Heart Disease & Stroke
- Hypertension and Chronic Renal Failure
- Hypertension and Diabetes:Treatment and Managment
- Hypertension and Obesity
- Hypertension and Sexual Dysfunction
- Hypertension – Stress and Stroke
- Hypertension in Children and Adolescents
- Hypertension in Pregnancy
- Hypertension: Advanced Treatments Approaches
- Hypertension: Diagnosis, Risk Assessment, Prevention and Treatment
- Hypertensive Retinopathy
- Pulmonary hypertension
- Therapies for Resistant Hypertension
Related Journals
Are you interested in
- Acute Coronary Syndrome (ACS) - GERIATRIC CARDIOLOGY 2025 (France)
- Acute Management of Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Advanced Imaging Techniques for Coronary Artery Disease - Interventional Cardiology 2025 (UK)
- Advanced Technologies in Cardiac Monitoring - Euro Cardiology Congress 2025 (Italy)
- Advanced Treatments Approaches - Hypertension 2025 (Italy)
- Advancements in Hypertension Research - Hypertension Congress-2025 (France)
- Advances in Cardiac Imaging - Molecular Cardiology 2025 (France)
- Advances in Cardiac Imaging for Precision Medicine - Euro Cardiology Congress 2025 (Italy)
- Advances in Cardiovascular Medicine - World Heart 2025 (Canada)
- Advances in Cardiovascular Medicine - Heart 2025 (Japan)
- Advances in Coronary Artery Disease Research - Euro Cardiology Congress 2025 (Italy)
- Advances in Heart Failure and Angina Diagnostics - Congestive Heart Failure-2025 (Switzerland)
- AF Screening With a 14-Day ECG Monitor - GERIATRIC CARDIOLOGY 2025 (France)
- Ageing - GERIATRIC CARDIOLOGY 2025 (France)
- Aging and Cardiovascular Disease - HEART CONGRESS 2025 (Germany)
- Aging and Neurodegenerative Diseases - HEART BRAIN 2025 (Japan)
- AI and Machine Learning in Cardiology - World Heart Congress 2025 (UAE)
- AI-Assisted Robotic Systems for Complex Interventional Procedures - Interventional Cardiology 2025 (UK)
- AI-Powered Image Analysis for Improved Diagnosis and Treatment Planning - Interventional Cardiology 2025 (UK)
- Anaesthesia and Cardiac Image - Heart Congress-2025 (Canada)
- Angiography & Interventional Cardiology - Clinical Cardiology 2025 (Canada)
- Arrhythmia Management and Electrophysiology - Molecular Cardiology 2025 (France)
- Arrhythmia treatment - CVDT 2025 (France)
- Arrhythmias & Electrophysiology - Hypertension 2025 (Italy)
- Arrhythmias and Electrophysiology - HEART CONGRESS 2025 (Germany)
- Arrhythmias and Electrophysiology - World Heart 2025 (Canada)
- Arrhythmias and Electrophysiology - Euro Cardiology 2025 (Germany)
- Artificial Intelligence and Machine Learning in Cardiology - Molecular Cardiology 2025 (France)
- Artificial Intelligence and Machine Learning in Cardiovascular Risk Prediction - Interventional Cardiology 2025 (UK)
- Artificial Intelligence in Cardiology - World Heart 2025 (Canada)
- Artificial Intelligence in Cardiology - CVDT 2025 (France)
- Artificial Intelligence in Cardiovascular Imaging - Interventional Cardiology 2025 (UK)
- Atherectomy Techniques for Peripheral Vascular Disease - Interventional Cardiology 2025 (UK)
- Atherosclerosis - Annual Cardiology 2025 (Canada)
- Atherosclerosis - WORLD CARDIOLOGY 2025 (Italy)
- Atherosclerosis and Lipid Management - Molecular Cardiology 2025 (France)
- Bifurcation Lesion Interventions - Interventional Cardiology 2025 (UK)
- Biodegradable Stents and Scaffolds - Interventional Cardiology 2025 (UK)
- Biomarkers in Cardiovascular Diseases - Euro Cardiology 2025 (Germany)
- Biomarkers in Cardiovascular Medicine - HEART CONGRESS 2025 (Germany)
- Biomarkers in Cardiovascular Medicine - CVDT 2025 (France)
- Biomaterials and Drug Delivery Systems for Cardiac Repair - Interventional Cardiology 2025 (UK)
- Bladder and Bowel Health - GERIATRIC CARDIOLOGY 2025 (France)
- Cardiac & Cardiovascular Research - Annual Cardiology 2025 (Canada)
- Cardiac and Cardiovascular Research - Clinical Cardiology 2025 (Canada)
- Cardiac and Heart Regeneration - Annual Cardiology 2025 (Canada)
- Cardiac Biomarkers in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Cardiac Electrophysiology - WORLD CARDIOLOGY 2025 (Italy)
- Cardiac Electrophysiology - CVDT 2025 (France)
- Cardiac Imaging - Clinical Cardiology 2025 (Canada)
- Cardiac Imaging & Diagnostics - Heart 2025 (Japan)
- Cardiac Imaging and Diagnostics - Euro Cardiology 2025 (Germany)
- Cardiac Nursing - Clinical Cardiology 2025 (Canada)
- Cardiac Nursing - CVDT 2025 (France)
- Cardiac nursing - Heart Congress-2025 (Canada)
- Cardiac Pharmacology - Annual Cardiology 2025 (Canada)
- Cardiac Pharmacology - WORLD CARDIOLOGY 2025 (Italy)
- Cardiac Pharmacology and Therapeutics - World Heart Congress 2025 (UAE)
- Cardiac Rehabilitation - WORLD CARDIOLOGY 2025 (Italy)
- Cardiac Rehabilitation and Patient Care Innovations - World Heart Congress 2025 (UAE)
- Cardiac Rehabilitation and Patient Wellness - Euro Cardiology 2025 (Germany)
- Cardiac Rehabilitation and Preventive Cardiology - Molecular Cardiology 2025 (France)
- Cardiac Rehabilitation and Preventive Cardiology - CVDT 2025 (France)
- Cardiac Rehabilitation and Recovery - World Heart 2025 (Canada)
- Cardiac Resynchronization Therapy in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Cardiac Surgery - Clinical Cardiology 2025 (Canada)
- Cardiac Surgery - Annual Cardiology 2025 (Canada)
- Cardiac Surgery - GERIATRIC CARDIOLOGY 2025 (France)
- Cardiac Surgery - Heart Congress-2025 (Canada)
- Cardiac Surgery: Emerging Techniques - Molecular Cardiology 2025 (France)
- Cardiac Toxicity and Oncology - Molecular Cardiology 2025 (France)
- Cardiac Toxicity and Oncology - CVDT 2025 (France)
- Cardiac Transplantation and Mechanical Circulatory Support - World Heart 2025 (Canada)
- Cardio-Metabolic Disorders - World Heart 2025 (Canada)
- Cardio-Oncology - HEART CONGRESS 2025 (Germany)
- Cardio-Oncology - Euro Cardiology 2025 (Germany)
- Cardio-Oncology - World Heart 2025 (Canada)
- Cardio-Oncology - WORLD CARDIOLOGY 2025 (Italy)
- Cardio-Oncology & Cardiotoxicity - Hypertension 2025 (Italy)
- Cardiology - Future Medicine - Clinical Cardiology 2025 (Canada)
- Cardiology - Future Medicine - Annual Cardiology 2025 (Canada)
- Cardiology - Future Medicine - WORLD CARDIOLOGY 2025 (Italy)
- Cardiology, Pediatrics, and Neurology - GERIATRIC CARDIOLOGY 2025 (France)
- Cardiometabolic Disorders and Diabetes - Heart 2025 (Japan)
- Cardiometabolic Health - GERIATRIC CARDIOLOGY 2025 (France)
- Cardiometabolic Health - GERIATRIC CARDIOLOGY 2025 (France)
- Cardiometabolic Syndrome: The Intersection of Diabetes and Cardiovascular Disease - Molecular Cardiology 2025 (France)
- Cardiomyopathies and Myocardial Diseases - Euro Cardiology 2025 (Germany)
- Cardiomyopathy and Stroke - CVDT 2025 (France)
- Cardiomyopathy symptoms - CVDT 2025 (France)
- Cardiomyopathy treatment - CVDT 2025 (France)
- Cardiovascular Biomarkers and Diagnostics - Euro Cardiology Congress 2025 (Italy)
- Cardiovascular Clinical Trials: Updates and Future Directions - Molecular Cardiology 2025 (France)
- Cardiovascular Complications of Diabetes - HEART CONGRESS 2025 (Germany)
- Cardiovascular Complications of Diabetes - CVDT 2025 (France)
- Cardiovascular Disease and Mental Health - Euro Cardiology Congress 2025 (Italy)
- Cardiovascular Disease in Aging Populations - Molecular Cardiology 2025 (France)
- Cardiovascular Diseases - Annual Cardiology 2025 (Canada)
- Cardiovascular Diseases - WORLD CARDIOLOGY 2025 (Italy)
- Cardiovascular diseases - CVDT 2025 (France)
- Cardiovascular Diseases - Heart Congress-2025 (Canada)
- Cardiovascular Effects of Aging - Euro Cardiology Congress 2025 (Italy)
- Cardiovascular failure - CVDT 2025 (France)
- Cardiovascular Genetics and Genomics - Euro Cardiology Congress 2025 (Italy)
- Cardiovascular Genetics and Genomics - Molecular Cardiology 2025 (France)
- Cardiovascular Genetics and Genomics - CVDT 2025 (France)
- Cardiovascular Genomics - HEART CONGRESS 2025 (Germany)
- Cardiovascular Imaging Advance - CVDT 2025 (France)
- Cardiovascular Imaging and Diagnostics - World Heart 2025 (Canada)
- Cardiovascular Implications of Diabetes - Euro Cardiology Congress 2025 (Italy)
- Cardiovascular Medicine - Heart Congress-2025 (Canada)
- Cardiovascular Nutrition and Dietetics - World Heart 2025 (Canada)
- Cardiovascular Nutrition and Lifestyle - HEART CONGRESS 2025 (Germany)
- Cardiovascular pharmacology - CVDT 2025 (France)
- Cardiovascular Pharmacology and Drug Development - Euro Cardiology Congress 2025 (Italy)
- Cardiovascular pharmacology and drug development - Euro Cardiology 2025 (Germany)
- Cardiovascular Pharmacology and Drug Development - World Heart 2025 (Canada)
- Cardiovascular Pharmacotherapy - Molecular Cardiology 2025 (France)
- Cardiovascular Regenerative Medicine - HEART CONGRESS 2025 (Germany)
- Cardiovascular Regenerative Medicine - CVDT 2025 (France)
- Cardiovascular Risk Assessment - Hypertension Congress-2025 (France)
- Cardiovascular Risk Assessment and Management - Euro Cardiology Congress 2025 (Italy)
- Cardiovascular surgery - Heart Congress-2025 (Canada)
- Cardiovascular Surgery and Interventions - World Heart 2025 (Canada)
- Cardiovascular Tech - WORLD CARDIOLOGY 2025 (Italy)
- Cardiovascular therapeutics - CVDT 2025 (France)
- Cardiovascular Toxicology and Pharmacology - Heart Congress-2025 (Canada)
- Case report studies on Cardiology - WORLD CARDIOLOGY 2025 (Italy)
- Case Reports On Cardiology - Clinical Cardiology 2025 (Canada)
- Cerebrovascular Disease & Stroke - GERIATRIC CARDIOLOGY 2025 (France)
- Cerebrovascular Disease & Stroke - GERIATRIC CARDIOLOGY 2025 (France)
- Chronic Angina - GERIATRIC CARDIOLOGY 2025 (France)
- Chronic Heart Failure - GERIATRIC CARDIOLOGY 2025 (France)
- Chronic Management of Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Chronic Total Occlusion Percutaneous Coronary Intervention - Interventional Cardiology 2025 (UK)
- Clinical and Experimental Cardiology - Clinical Cardiology 2025 (Canada)
- Clinical Cardiology - Annual Cardiology 2025 (Canada)
- Clinical Cardiology - WORLD CARDIOLOGY 2025 (Italy)
- Clinical Cardiology - Heart Congress-2025 (Canada)
- Clinical case report - Hypertension 2025 (Italy)
- Clinical Case Reports on Cardiology - Annual Cardiology 2025 (Canada)
- Clinical Case reports on cardiology - Heart Congress-2025 (Canada)
- Clinical Case Studies and Research Presentations - HEART BRAIN 2025 (Japan)
- Clinical Cases and Challenges in Cardiovascular Medicine - Euro Cardiology 2025 (Germany)
- Clinical Management of Hypertension - Hypertension Congress-2025 (France)
- Cognitive Decline and Cardiovascular Risk Factors - HEART BRAIN 2025 (Japan)
- Cognitive Function and Decision Making - HEART BRAIN 2025 (Japan)
- Congenital heart disease - GERIATRIC CARDIOLOGY 2025 (France)
- Congenital Heart Disease - Heart Congress-2025 (Canada)
- Congestive Heart Failure - Annual Cardiology 2025 (Canada)
- Congestive Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Coronary Artery Disease & Atherosclerosis - Hypertension 2025 (Italy)
- Coronary Artery Disease (CAD) - WORLD CARDIOLOGY 2025 (Italy)
- Coronary Artery Disease in Special Populations (e.g., Diabetes, Women) - Interventional Cardiology 2025 (UK)
- Coronary Artery Diseases - CVDT 2025 (France)
- COVID-19 & Cardiovascular Complications - Hypertension 2025 (Italy)
- CRISPR in Cardiovascular Research - HEART CONGRESS 2025 (Germany)
- Critical Cardiac Care - WORLD CARDIOLOGY 2025 (Italy)
- Critical Care & Resuscitation - GERIATRIC CARDIOLOGY 2025 (France)
- Critical Care and Vascular Medicine - GERIATRIC CARDIOLOGY 2025 (France)
- Current research in Cardiology - Clinical Cardiology 2025 (Canada)
- Current Research in Cardiology - Heart Congress-2025 (Canada)
- Device Therapy for Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Diabetes & Obesity - Annual Cardiology 2025 (Canada)
- Diabetes, Obesity & Stroke - Clinical Cardiology 2025 (Canada)
- Diabetics, Obesity and stroke - WORLD CARDIOLOGY 2025 (Italy)
- Diet & Exercise for Hypertension - Hypertension 2025 (Italy)
- Digital Health & AI in Cardiology - Heart 2025 (Japan)
- Digital Health and Telecardiology - HEART CONGRESS 2025 (Germany)
- Drug-Coated Balloons and Stents for Peripheral Vascular Disease - Interventional Cardiology 2025 (UK)
- Echocardiography - Annual Cardiology 2025 (Canada)
- Echocardiography - WORLD CARDIOLOGY 2025 (Italy)
- Echocardiography & Cardiac Imaging - Heart Congress-2025 (Canada)
- Economic Burden of Hypertension - Hypertension Congress-2025 (France)
- Emerging Biomarkers in Cardiovascular Disease - Molecular Cardiology 2025 (France)
- Emerging Percutaneous Coronary Intervention Techniques for Acute Myocardial Infarction - Interventional Cardiology 2025 (UK)
- Emerging Technologies - WORLD CARDIOLOGY 2025 (Italy)
- Emerging Technologies in Heart-Brain Research - HEART BRAIN 2025 (Japan)
- Emerging Therapies for Atrial Fibrillation - Euro Cardiology Congress 2025 (Italy)
- Emerging Therapies for Critical Limb Ischemia - Interventional Cardiology 2025 (UK)
- Emerging Therapies in Atrial Fibrillation and Arrhythmias - Heart 2025 (Japan)
- Endovascular Treatment of Peripheral Arterial Disease - Interventional Cardiology 2025 (UK)
- Epigenetics in Cardiovascular Diseases - HEART CONGRESS 2025 (Germany)
- Ethical and Societal Issues in Managing Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Ethical Considerations and Regulatory Frameworks for AI in Cardiology - Interventional Cardiology 2025 (UK)
- Ethical Considerations in Cardiovascular Research - Euro Cardiology Congress 2025 (Italy)
- Ethics in Cardiovascular Research and Practice - Euro Cardiology 2025 (Germany)
- Ethics in Heart-Brain Health Care - HEART BRAIN 2025 (Japan)
- Exercise and Rehabilitation in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Exploring Vitamin D's Role in Cardiovascular Health - HEART CONGRESS 2025 (Germany)
- Functional Cardiac Imaging for Risk Assessment - Interventional Cardiology 2025 (UK)
- Future Directions in Cardiovascular Medicine - Euro Cardiology 2025 (Germany)
- Future Directions in Heart Failure and Angina Research - Congestive Heart Failure-2025 (Switzerland)
- Future directions in Heart Transplantation and Artificial Hearts - HEART CONGRESS 2025 (Germany)
- Gene & Tissue Regeneration - GERIATRIC CARDIOLOGY 2025 (France)
- Gene Therapy for Cardiovascular Diseases - Interventional Cardiology 2025 (UK)
- Genetics and Precision Medicine in Cardiology - World Heart 2025 (Canada)
- Genomic and Molecular Markers for Patient Stratification - Interventional Cardiology 2025 (UK)
- Genomics and Proteomics in Cardiology - Euro Cardiology 2025 (Germany)
- Geroscience and Cardiovascular Health - GERIATRIC CARDIOLOGY 2025 (France)
- Gestational hypertension - Hypertension 2025 (Italy)
- Global Cardiovascular Health and Policies - World Heart 2025 (Canada)
- Global Perspectives on Heart Failure and Angina Management - Congestive Heart Failure-2025 (Switzerland)
- Global Perspectives on Hypertension - Hypertension Congress-2025 (France)
- Health Disparities and Access to Care - HEART BRAIN 2025 (Japan)
- Health Promotitive Cardiology - GERIATRIC CARDIOLOGY 2025 (France)
- Healthcare & Technologies - Hypertension 2025 (Italy)
- Healthcare and Chronic Diseases - Hypertension 2025 (Italy)
- Healthcare and Global Economics - Hypertension 2025 (Italy)
- Heart Arrhythmia - World Heart Congress 2025 (UAE)
- Heart Diagnosis & Heart Devices - Clinical Cardiology 2025 (Canada)
- Heart Disease & Failure - Clinical Cardiology 2025 (Canada)
- Heart Disease in Women - World Heart Congress 2025 (UAE)
- Heart Diseases & Heart Failure - Annual Cardiology 2025 (Canada)
- Heart Diseases & Risk Factors - Heart 2025 (Japan)
- Heart Failure and Angina in Special Populations - Congestive Heart Failure-2025 (Switzerland)
- Heart Failure and Cardiac Regeneration - Heart 2025 (Japan)
- Heart failure and cardiomyopathies - GERIATRIC CARDIOLOGY 2025 (France)
- Heart Failure and Transplant Cardiology - WORLD CARDIOLOGY 2025 (Italy)
- Heart Failure Management - HEART CONGRESS 2025 (Germany)
- Heart Failure Management - World Heart 2025 (Canada)
- Heart Failure Management - Euro Cardiology 2025 (Germany)
- Heart failure medications - CVDT 2025 (France)
- Heart Failure, Angina, and Comorbidities - Congestive Heart Failure-2025 (Switzerland)
- Heart Failure, Angina, and Kidney Disease - Congestive Heart Failure-2025 (Switzerland)
- Heart Failure, Angina, and Obesity - Congestive Heart Failure-2025 (Switzerland)
- Heart Failure, Angina, and Pregnancy - Congestive Heart Failure-2025 (Switzerland)
- Heart Failure: New Therapeutic Approaches - Molecular Cardiology 2025 (France)
- Heart Rate Variability (HRV) and Mental Health - HEART BRAIN 2025 (Japan)
- Heart Regeneration - Clinical Cardiology 2025 (Canada)
- Heart Regeneration Using Induced Pluripotent Stem Cells (iPSCs) - HEART CONGRESS 2025 (Germany)
- Heart Rhythm - Annual Cardiology 2025 (Canada)
- Heart Surgery - WORLD CARDIOLOGY 2025 (Italy)
- Heart Transplant Complications - World Heart Congress 2025 (UAE)
- Heart Transplantation - CVDT 2025 (France)
- Heart Transplantation and Mechanical Circulatory Support - Molecular Cardiology 2025 (France)
- Heart Valve Disease: Innovations in Diagnosis and Treatment - Molecular Cardiology 2025 (France)
- Hot Topics in Cardiovascular Research - Euro Cardiology 2025 (Germany)
- Hypertension - Clinical Cardiology 2025 (Canada)
- Hypertension - GERIATRIC CARDIOLOGY 2025 (France)
- Hypertension - WORLD CARDIOLOGY 2025 (Italy)
- Hypertension - World Heart Congress 2025 (UAE)
- Hypertension - Hypertension 2025 (Italy)
- Hypertension - Heart Congress-2025 (Canada)
- Hypertension & Cardiac Arrest - Hypertension 2025 (Italy)
- Hypertension & Diabetes - Hypertension 2025 (Italy)
- Hypertension & Obesity - Hypertension 2025 (Italy)
- Hypertension & Stroke - Annual Cardiology 2025 (Canada)
- Hypertension & Stroke Prevention - Heart 2025 (Japan)
- Hypertension and Aging - Hypertension Congress-2025 (France)
- Hypertension and Cardiovascular Diseases - Hypertension Congress-2025 (France)
- Hypertension and Cardiovascular Risk - Molecular Cardiology 2025 (France)
- Hypertension and Cardiovascular Risk Management - World Heart 2025 (Canada)
- Hypertension and Co-morbidities - Hypertension Congress-2025 (France)
- Hypertension and Endocrine Disorders - Hypertension Congress-2025 (France)
- Hypertension and Environmental Factors - Hypertension Congress-2025 (France)
- Hypertension and Gastrointestinal Disorders - Hypertension Congress-2025 (France)
- Hypertension and Infectious Diseases - Hypertension Congress-2025 (France)
- Hypertension and Lifestyle Factors - Hypertension Congress-2025 (France)
- Hypertension and Mental Health - Hypertension Congress-2025 (France)
- Hypertension and Neurological Disorders - Hypertension Congress-2025 (France)
- Hypertension and Obesity - Hypertension Congress-2025 (France)
- Hypertension and Sexual Health - Hypertension Congress-2025 (France)
- Hypertension and Sleep Disorders - Hypertension Congress-2025 (France)
- Hypertension and Vascular Health - HEART CONGRESS 2025 (Germany)
- Hypertension and Vascular Health - CVDT 2025 (France)
- Hypertension in Pregnancy - Hypertension Congress-2025 (France)
- Hypertension Screening and Diagnosis - Hypertension Congress-2025 (France)
- Hypertension treatment - CVDT 2025 (France)
- Hypertension Treatments - Hypertension 2025 (Italy)
- Hypertension – Stress & Stroke - Hypertension 2025 (Italy)
- Hypertension: Genetics and Genomics - Hypertension Congress-2025 (France)
- Hypertension’s Impact on Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Immunomodulation in Myocarditis - HEART CONGRESS 2025 (Germany)
- Innovations in Cardiac Imaging - Euro Cardiology Congress 2025 (Italy)
- Innovations in Cardiac Imaging - HEART CONGRESS 2025 (Germany)
- Innovations in Cardiovascular Medicine - Euro Cardiology 2025 (Germany)
- Innovations in Heart Transplantation and Mechanical Circulatory Support - Euro Cardiology Congress 2025 (Italy)
- Innovations in Interventional Cardiology - Molecular Cardiology 2025 (France)
- Innovations in Monitoring Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Integrated Care Models for Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Integrative Approaches to Neurocardiology - HEART BRAIN 2025 (Japan)
- Interdisciplinary Collaboration - HEART BRAIN 2025 (Japan)
- Intervention for Older Patients with Non–STEMI - GERIATRIC CARDIOLOGY 2025 (France)
- Interventional Cardiology - HEART CONGRESS 2025 (Germany)
- Interventional Cardiology - Heart Congress-2025 (Canada)
- Interventional Cardiology & Surgery - Heart 2025 (Japan)
- Interventional Cardiology and Surgery - Euro Cardiology 2025 (Germany)
- Intravascular Imaging for Guiding Interventional Procedures - Interventional Cardiology 2025 (UK)
- Ischemic Heart Disease - GERIATRIC CARDIOLOGY 2025 (France)
- Kinlessness in Older Adults with Advanced HF - GERIATRIC CARDIOLOGY 2025 (France)
- Latest Developments in Heart Failure Management - Euro Cardiology Congress 2025 (Italy)
- Left Atrial Appendage Closure Devices - Interventional Cardiology 2025 (UK)
- Left Main Coronary Artery Interventions - Interventional Cardiology 2025 (UK)
- Lifestyle Interventions for Dual Health Benefits - HEART BRAIN 2025 (Japan)
- Long COVID and Cardiovascular Health - HEART CONGRESS 2025 (Germany)
- Long-Term Follow-Up and Risk Management - Interventional Cardiology 2025 (UK)
- Machine Learning Algorithms for Predicting Patient Outcomes - Interventional Cardiology 2025 (UK)
- Mechanisms of Cardiovascular Disease Progression - Euro Cardiology Congress 2025 (Italy)
- Mental Health Impact of Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Microbiome and Cardiovascular Health - HEART CONGRESS 2025 (Germany)
- Mindfulness and Cognitive Behavioural Therapies - HEART BRAIN 2025 (Japan)
- Minimally Invasive Cardiac Procedures - World Heart Congress 2025 (UAE)
- Minimally Invasive Coronary Intervention (PCI) Techniques - Interventional Cardiology 2025 (UK)
- Mitochondrial Dysfunction in Cardiac Disorders - HEART CONGRESS 2025 (Germany)
- Molecular Cardiology - Clinical Cardiology 2025 (Canada)
- Molecular cardiology - Heart Congress-2025 (Canada)
- mRNA-Based Therapeutics for Cardiovascular Diseases - HEART CONGRESS 2025 (Germany)
- Nanomedicine in Cardiovascular Disease - Interventional Cardiology 2025 (UK)
- Nanotechnology in Cardiovascular Medicine - HEART CONGRESS 2025 (Germany)
- Nanotechnology in Cardiovascular Medicine - World Heart 2025 (Canada)
- New Strategies for Early Diagnosis and Risk Stratification - Interventional Cardiology 2025 (UK)
- Novel Antithrombotic Therapies - Interventional Cardiology 2025 (UK)
- Novel Drug Delivery Systems for Cardiovascular Therapy - Interventional Cardiology 2025 (UK)
- Novel Drug Therapies for Cardiovascular Conditions - Euro Cardiology Congress 2025 (Italy)
- Novel Drug Therapies for Cardiovascular Conditions - CVDT 2025 (France)
- Novel Therapies and Drug Development - Hypertension Congress-2025 (France)
- Novel Therapies and Emerging Treatments for Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Nuclear Cardiology - Clinical Cardiology 2025 (Canada)
- Nutrition and Hypertension - Hypertension Congress-2025 (France)
- Nutrition, Diet, and Cardiovascular Health - Molecular Cardiology 2025 (France)
- Nutrition, Diet, and Cardiovascular Health - CVDT 2025 (France)
- Obesity and Cardiovascular Risk - World Heart Congress 2025 (UAE)
- Oncology and Geriatrics - GERIATRIC CARDIOLOGY 2025 (France)
- Open-Heart Surgery - Heart Congress-2025 (Canada)
- Optimal Medical Therapy for Acute Coronary Syndromes - Interventional Cardiology 2025 (UK)
- Paediatric Cardiology - Annual Cardiology 2025 (Canada)
- Palliative Care for Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Pathophysiology of Congestive Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Patient Education and Counseling - Interventional Cardiology 2025 (UK)
- Patient-Centered Decision-Making in Interventional Cardiology - Interventional Cardiology 2025 (UK)
- Pediatric & Geriatric Cardiology - Heart 2025 (Japan)
- Pediatric and Adolescent Hypertension - Hypertension Congress-2025 (France)
- Pediatric and Congenital Cardiology - Molecular Cardiology 2025 (France)
- Pediatric Cardiology - Clinical Cardiology 2025 (Canada)
- Pediatric Cardiology - HEART CONGRESS 2025 (Germany)
- Pediatric Cardiology - World Heart 2025 (Canada)
- Pediatric Cardiology - WORLD CARDIOLOGY 2025 (Italy)
- Pediatric Cardiology - CVDT 2025 (France)
- Pediatric Cardiology - World Heart Congress 2025 (UAE)
- Pediatric Cardiology and Congenital Heart Diseases - Euro Cardiology 2025 (Germany)
- Pediatric Hypertension - Hypertension 2025 (Italy)
- Percutaneous Coronary Interventions (PCI) and Surgery - GERIATRIC CARDIOLOGY 2025 (France)
- Percutaneous Left Atrial Appendage Closure Devices - Interventional Cardiology 2025 (UK)
- Peripheral Artery Disease and Vascular Health - Molecular Cardiology 2025 (France)
- Personalized Antiplatelet Therapy Strategies - Interventional Cardiology 2025 (UK)
- Personalized Medicine in Cardiovascular Treatment - World Heart Congress 2025 (UAE)
- Personalized Medicine in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Pharmacogenomics and Hypertension - Hypertension Congress-2025 (France)
- Pharmacogenomics in Antithrombotic Therapy - Interventional Cardiology 2025 (UK)
- Pharmacogenomics in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Pharmacological Management of Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Policy Implications for Integrated Care - HEART BRAIN 2025 (Japan)
- Pregnancy-Related Heart Conditions - WORLD CARDIOLOGY 2025 (Italy)
- Preventive Cardiology & Rehabilitation - Heart 2025 (Japan)
- Preventive Cardiology and Lifestyle Medicine - World Heart 2025 (Canada)
- Preventive Cardiology and Risk Management - Euro Cardiology 2025 (Germany)
- Public Health and Cardiovascular Disease Prevention - Molecular Cardiology 2025 (France)
- Public Health Initiatives and Education - HEART BRAIN 2025 (Japan)
- Public Health Policies and Hypertension - Hypertension Congress-2025 (France)
- Pulmonary Hypertension - Hypertension 2025 (Italy)
- Quality Improvement and Patient-Centered Care - Interventional Cardiology 2025 (UK)
- Quality of Life and Patient-Centered Care in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Regenerative Medicine and Stem Cell Therapy for Heart Disease - World Heart Congress 2025 (UAE)
- Regenerative Medicine in Cardiology - Heart 2025 (Japan)
- Rehabilitation and Quality of Life - Euro Cardiology 2025 (Germany)
- Role of Imaging in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Sleep Disorders in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Social Connections and health innovations - HEART BRAIN 2025 (Japan)
- Sports and Exercise Cardiology - GERIATRIC CARDIOLOGY 2025 (France)
- Sports Cardiology - Annual Cardiology 2025 (Canada)
- Sports Cardiology & Exercise Medicine - Heart 2025 (Japan)
- Stem Cell Therapy for Myocardial Repair - Interventional Cardiology 2025 (UK)
- Stem Cells and Regenerative Medicine - Molecular Cardiology 2025 (France)
- Stress, Resilience and Emotions - HEART BRAIN 2025 (Japan)
- Structural Heart Disease in the Elderly - Interventional Cardiology 2025 (UK)
- Surgical Interventions in Heart Failure and Angina - Congestive Heart Failure-2025 (Switzerland)
- Tailored Interventional Strategies Based on Patient-Specific Factors - Interventional Cardiology 2025 (UK)
- Tailoring Treatments to Age and Frailty - GERIATRIC CARDIOLOGY 2025 (France)
- Targeting Inflammation in Atherosclerosis - HEART CONGRESS 2025 (Germany)
- Telecardiology and Remote Monitoring - Molecular Cardiology 2025 (France)
- The Future of Cardiovascular Drug Delivery Systems - Euro Cardiology Congress 2025 (Italy)
- The Future of Cardiovascular Drug Delivery Systems - CVDT 2025 (France)
- The Gut-Heart Axis - HEART CONGRESS 2025 (Germany)
- The Gut-Heart Connection - World Heart Congress 2025 (UAE)
- The Impact of Artificial Sweeteners on Cardiovascular Health - HEART CONGRESS 2025 (Germany)
- The Impact of Lifestyle Factors on Cardiovascular Health - Euro Cardiology Congress 2025 (Italy)
- The Role of Artificial Hearts and Mechanical Circulatory Support - World Heart Congress 2025 (UAE)
- The Role of Inflammation in Cardiovascular Diseases - Euro Cardiology Congress 2025 (Italy)
- Thrombosis and Hemostasis in Cardiovascular Disease - Molecular Cardiology 2025 (France)
- Tissue Engineering for Cardiac Regeneration - Interventional Cardiology 2025 (UK)
- Transcatheter Aortic Valve Replacement (TAVR) Advancements - Interventional Cardiology 2025 (UK)
- Transcatheter Mitral and Tricuspid Valve Therapies - Interventional Cardiology 2025 (UK)
- Transcatheter Mitral Valve Repair and Replacement - Interventional Cardiology 2025 (UK)
- Transcatheter Tricuspid Valve Repair and Replacement - Interventional Cardiology 2025 (UK)
- usative Factors & Risk Assessment - Hypertension 2025 (Italy)
- Valvular Heart Disease - GERIATRIC CARDIOLOGY 2025 (France)
- Valvular Heart Diseases - Hypertension 2025 (Italy)
- Vascular Biology - Clinical Cardiology 2025 (Canada)
- Vascular Biology and Hypertension - World Heart 2025 (Canada)
- Vascular Medicine and Hypertension - Euro Cardiology 2025 (Germany)
- Wearable Devices and Remote Monitoring - Interventional Cardiology 2025 (UK)
- Wearable Technology - HEART CONGRESS 2025 (Germany)
- Wearable Technology and Remote Monitoring - World Heart Congress 2025 (UAE)
- Women and Cardiac Arrhythmia - Annual Cardiology 2025 (Canada)
- Women and Heart Disease - HEART CONGRESS 2025 (Germany)
- Women Heart Health - Annual Cardiology 2025 (Canada)
- Women’s Cardiology - WORLD CARDIOLOGY 2025 (Italy)
- Women’s Cardiovascular Health - Molecular Cardiology 2025 (France)
- Women’s Cardiovascular Health - World Heart 2025 (Canada)
- Women’s Cardiovascular Health - CVDT 2025 (France)
- Women’s Heart Health - Heart 2025 (Japan)